Skip to content

News & calendar

news: as of 2026-10-07
What the marks mean

Importance is a model-assigned 1–5 on published stories, not a market forecast.

Impact on a scheduled row is a company-prominence tier (High/Medium from graph centrality and size; Low only on curated minor events), not a magnitude forecast.

An earnings date marked confirmed is company-confirmed by Yahoo Finance; estimated is not yet announced. Unmarked rows carry no recorded provenance.

Economic releases are macro and carry no industry, so they stay in every view. A release with no value has not printed yet and says so rather than showing a zero.

Upcoming events across the tracked universe; past events are archived, with outcomes added where available — curated and cited, never fabricated. A past row without one reads “outcome pending”.

A lock-up or index change row adds one line of arithmetic — shares becoming sellable, or shares index funds must buy, as a share of float — read off the prospectus or the index methodology, with both numbers cited in the row. It states the mechanics, not a price move. A lock-up date derived as IPO + 180 days stays estimated until the company states it.

Ahead

scheduled · today and tomorrow · calendar refreshed 2026-10-07

Wed · 7 Oct · today

Thu · 8 Oct

Behind

published · newest first

Sun · 30 Aug

product

13:30
Business Wire

L3Harris Celebrates Successful Launch of NASA's Nancy Grace Roman Space Telescope

L3Harris marked the successful launch of NASA's Nancy Grace Roman Space Telescope. No contract or program figures appear in the supplied text.

Markets open original ↗

product

12:23
Business Wire

Alnylam Presents New Data at ESC Congress 2026 Reinforcing Strength in RNAi-Powered TTR Silencing Across ATTR-CM Patient Populations and Treatment Settings

Alnylam presented new data at ESC Congress 2026 on RNAi-powered TTR silencing across ATTR-CM patient populations and treatment settings. No figures appear in the supplied text.

Markets open original ↗

product

11:45
Business Wire

Bayer Announces Phase III REVEAL Study with Investigational PET Radiotracer Iodine 124 Evuzamitide Presented as Late-Breaker at ESC 2026

Bayer said its Phase III REVEAL study of the investigational PET radiotracer iodine 124 evuzamitide was presented as a late-breaker at ESC 2026. No trial figures appear in the supplied text.

Markets open original ↗

macro

07:27
CNBC

Trump announces deal with Venezuela to secure more than 65 billion barrels of oil reserves

President Trump announced a deal with Venezuela to secure more than 65 billion barrels of oil reserves.

Article preview

Skip Navigation Markets Business Investing Tech Politics & Policy Video Watchlist Investing Club PRO Livestream Menu Key Points The U.S. struck a deal with Venezuela to get majority control of more than 65 billion barrels of oil reserves, according to President Donald Trump. Trump said the deal comes "at no cost to" U.S. taxpayers. In this article @CL.1 @LCO27F Follow your favorite stocks CREATE FREE ACCOUNT US President Donald Trump speaks in the Rose Garden of the White House in Washington, DC, on Aug. 24, 2026. Jim Watson | AFP | Getty Images The U.S. struck a deal with Venezuela…

Markets open original ↗

personnel

03:09
Yahoo Finance

Boeing (BA) Names Ryan L Shedd Senior Vice President And Controller

Boeing named Ryan L. Shedd senior vice president and controller.

Markets open original ↗

The wire

everything that arrived · 7 days